Simulations Plus to Present at the KeyBanc Capital Markets Virtual Life Sciences & MedTech Investor Forum
Simulations Plus, Inc. (SLP) CEO to host fireside chat at KeyBanc Capital Markets Virtual Life Sciences & MedTech Investor Forum. Live webcast available for replay for 90 days.
03/13/2024 - 08:30 AM
LANCASTER, Calif. --(BUSINESS WIRE)--
Simulations Plus, Inc. (Nasdaq: SLP) (“Simulations Plus”), a leading provider of modeling and simulation software and services for pharmaceutical safety and efficacy, today announced that Shawn O’Connor, chief executive officer, will be hosting a fireside chat at the KeyBanc Capital Markets Virtual Life Sciences & MedTech Investor Forum on Wednesday, March 20, 2024, at 4:30 p.m. Eastern Time. In addition, Mr. O’Connor will be meeting one-on-one with investors throughout the day.
The live webcast of the Company’s presentation can be accessed via this link and also on the Investors page of the Simulations Plus website where it will be available for replay for approximately 90 days following the event.
About Simulations Plus
Serving clients worldwide for more than 25 years, Simulations Plus is a leading provider in the biosimulation market providing software and consulting services supporting drug discovery, development, research, and regulatory submissions. We offer solutions that bridge artificial intelligence (AI)/machine learning, physiologically based pharmacokinetics, quantitative systems pharmacology/toxicology, and population PK/PD modeling approaches. Our technology is licensed and applied by major pharmaceutical, biotechnology, and regulatory agencies worldwide. For more information, visit our website at www.simulations-plus.com . Follow us on LinkedIn | X | YouTube .
Environmental, Social, and Governance (ESG)
We focus our Environmental, Social, and Governance (ESG) efforts where we can have the most positive impact. To learn more about our latest initiatives and priorities, please visit our website to read our 2023 ESG update .
View source version on businesswire.com: https://www.businesswire.com/news/home/20240313658000/en/
Simulations Plus Investor Relations
renee.bouche@simulations-plus.com
Financial Profiles
slp@finprofiles.com
Source: Simulations Plus, Inc.
When is Shawn O'Connor hosting a fireside chat at KeyBanc Capital Markets Virtual Life Sciences & MedTech Investor Forum?
Shawn O'Connor will be hosting the fireside chat on Wednesday, March 20, 2024, at 4:30 p.m. Eastern Time.
Where can the live webcast of the presentation be accessed?
The live webcast can be accessed via a link provided by the company and on the Investors page of the Simulations Plus website.
How long will the webcast be available for replay?
The webcast will be available for replay for approximately 90 days following the event.
Simulations Plus Inc.
NASDAQ:SLP
SLP Rankings
#3207 Ranked by Stock Gains
SLP Stock Data
Industry
Computer Systems Design Services
Sector
Professional, Scientific, and Technical Services
Tags
Technology Services, Packaged Software, Professional, Scientific, and Technical Services, Computer Systems Design Services
Country
US
City
Lancaster
About SLP
simulations plus, inc. (nasdaq: slp) is the premier developer of modeling & simulation software and consulting services supporting drug discovery, development research and regulatory submissions. we partner with companies to provide a data-driven, ‘strategic modeling methodology’, starting in early discovery, continuing through preclinical/clinical development, and concluding with clinical trials/post approval. with our subsidiaries, cognigen corporation and dilisym services, we offer #1-ranked, easy-to-use software (gastroplus™, admet predictor™, kiwi™, dilisym®, nafldsym®, pkplus™, and more) to bridge data mining, compound library screening with qsar models, pbpk/tk modeling & simulation in animals and humans following administration around the body, and quantitative systems pharmacology approaches. simulations plus technology is licensed to and used by regulatory agencies worldwide. for over 20 years, simulations plus has partnered with our clients to reduce costs and accelerate res
